BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This therapeutic strategy has been adopted in only two cases with concomitant BCR::ABL1 and CALR, and outcome data were available just in one case, which obtained complete remission of both CML and Ph-negative MPN with undetectable genetic markers (Boddu et al., 2018).